Agenda

Return

C. 66

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	December 7, 2021

Contra

Costa

County

Subject:

Purchase Order with Sanofi Pasteur, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/07/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Irene Segovia

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 7, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a Purchase Order with Sanofi Pasteur, Inc., in an amount not to exceed $375,000 for the purchase of vaccines and injectable medications at the Contra Costa Regional Medical Center (CCRMC) and Health Centers, for the period from January 1, 2022, through December 31, 2022.

FISCAL IMPACT:

Approval of this purchase order will result in expenditures of up to $375,000 for vaccines and injectable medications and will be 100% funded by Hospital Enterprise Fund I revenues.

BACKGROUND:

Sanofi Pasteur, Inc. furnishes pharmaceuticals for patient care provided in the hospital and the clinics. These vaccines and other injectable medications are essential for patient care. Sanofi is the maker of critical injectables for the hospital including Insulin for Type I and Type II diabetic patients, vaccines, and different immune globulin formulations including Immune globulin intravenous (IGIV), a life-saving medication used to treat primary immunodeficiency to reduce the risk of infection in individuals with poorly functioning immune systems. IGIV is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysms caused by a weakening of the main artery in the heart associated with Kawasaki syndrome.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the County will not be able to provide needed vaccines and other pharmaceutical products to our patient population at CCRMC and Health Centers. As part of our responsibility as a health care organization, we must provide needed vaccinations to our patient population to prevent disease, as well as prevent the spread of disease.